Paul Awolade

Synthesis, antimicrobial evaluation, and in silico studies of quinoline—1H-1,2,3-triazole molecular hybrids

Paul Awolade, Nosipho Cele, Nagaraju Kerru et al. · Molecular Diversity · 2020 · 69 citations

Pharmacy, Chemistry, Medicinal Chemistry +13

Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition

Lalitha Gummidi, Nagaraju Kerru, Oluwakemi Ebenezer et al. · Bioorganic Chemistry · 2021 · 69 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells

Sanjeev Dhawan, Nagaraju Kerru, Paul Awolade et al. · Bioorganic & Medicinal Chemistry · 2018 · 61 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

New library of pyrazole–imidazo[1,2‐α]pyridine molecular conjugates: Synthesis, antibacterial activity and molecular docking studies

Oluwakemi Ebenezer, Paul Awolade, Neil A. Koorbanally et al. · Chemical Biology & Drug Design · 2019 · 38 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline–1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation

Nosipho Cele, Paul Awolade, Pule Seboletswe et al. · Pharmaceuticals · 2022 · 35 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17